Abiopharma

Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies

OTCID symbol attribute type Exchange was changed. Previous value: -. New value: OTCID.

New Form POS AM - Inozyme Pharma, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-153585 Size: 22 KB

New Form 6-K - Inspira Technologies OXY B.H.N. Ltd Filed: 2025-07-01 AccNo: 0001213900-25-060005 Size: 36 KB

New Form 4 - CEL SCI CORP Filed: 2025-07-01 AccNo: 0001236030-25-000005 Size: 4 KB

New Form 6-K - Haleon plc Filed: 2025-07-01 AccNo: 0001654954-25-007574 Size: 24 KB

New Form 8-K - Inozyme Pharma, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-153582 Size: 322 KB Item 1.02: Termination of a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item …

Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering

New Form 424B5 - Inspira Technologies OXY B.H.N. Ltd Filed: 2025-07-01 AccNo: 0001213900-25-060004 Size: 25 KB

New Form 4 - CEL SCI CORP Filed: 2025-07-01 AccNo: 0001236030-25-000004 Size: 4 KB

New Form 8-K - IGM Biosciences, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-153576 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial …

New Form SC 14D9/A - Inozyme Pharma, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-153577 Size: 17 KB

New Form 8-K - FEMASYS INC Filed: 2025-07-01 AccNo: 0001140361-25-024313 Size: 183 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SC TO-T/A - Inozyme Pharma, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-153574 Size: 42 KB

Synaptongenix Notification (SNPX)